药明康德

- 603259

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2025  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015 
药明康德(603259) 利润表
单位:万元
报表日期2025-03-312024-12-312024-09-302024-06-302024-03-31
一、营业总收入965,459.533,924,143.142,770,200.231,724,091.83798,193.42
营业收入965,459.533,924,143.142,770,200.231,724,091.83798,193.42
二、营业总成本671,212.902,734,226.821,996,716.401,220,365.52564,390.89
营业成本557,452.922,296,451.551,644,025.611,045,393.69493,838.25
营业税金及附加8,473.6930,118.1021,878.4214,687.626,853.20
销售费用19,405.1974,538.8454,658.2335,752.1817,909.39
管理费用56,279.43287,934.20186,946.81121,223.5657,585.97
财务费用7,160.84-78,668.36-6,196.96-60,322.42-42,436.18
研发费用22,440.84123,852.5095,404.2863,630.8930,640.26
资产减值损失----------
公允价值变动收益-4,593.8618,695.7621,764.65-9,958.79-8,401.15
投资收益153,765.3160,416.24-16,480.962,237.94-892.51
其中:对联营企业和合营企业的投资收益6,400.2824,506.4719,895.0211,164.913,414.39
汇兑收益----------
三、营业利润429,274.881,158,017.47789,086.93507,845.41230,984.72
加:营业外收入15.282,225.48558.69403.59166.43
减:营业外支出1,300.806,261.784,216.013,293.621,411.74
其中:非流动资产处置损失----------
四、利润总额427,989.361,153,981.16785,429.61504,955.38229,739.41
减:所得税费用56,442.47197,207.21125,268.4676,870.8133,854.09
五、净利润371,546.88956,773.95660,161.15428,084.57195,885.32
归属于母公司所有者的净利润367,196.10945,030.84653,293.47423,982.20194,221.07
少数股东损益4,350.7911,743.116,867.684,102.371,664.25
六、每股收益
基本每股收益(元/股)1.29003.28002.25001.46000.6700
稀释每股收益(元/股)1.28003.26002.24001.45000.6600
七、其他综合收益11,847.3418,571.89-335.381,473.37-21,372.14
八、综合收益总额383,394.23975,345.84659,825.77429,557.94174,513.18
归属于母公司所有者的综合收益总额379,206.41963,889.15652,977.80425,692.55173,184.52
归属于少数股东的综合收益总额4,187.8211,456.696,847.973,865.391,328.66
下载全部历史数据到excel中 返回页顶